Data investigation
GLP-1 Units to mg Dosage Chart: Semaglutide & Tirzepatide
Compounded semaglutide and tirzepatide are dosed in mg but drawn in insulin-syringe units. The complete unit-to-mg chart for common compounded concentrations, the formula behind it, and worked answers like how many units is 2.5 mg of tirzepatide.
This dosing chart is part of Weight Loss Rankings' living editorial database — 1,160+ research articles and 630+ editorially reviewed GLP-1 telehealth providers, sourced only from primary FDA labels and peer-reviewed PubMed literature.
Compounded semaglutide and tirzepatide are prescribed in milligrams but drawn into the syringe in units — and getting that conversion wrong is one of the most common compounded GLP-1 dosing errors. The reason is that the vial is liquid, the syringe is a U-100 insulin syringe, and the relationship between "units on the syringe" and "milligrams of drug delivered" depends entirely on the concentration printed on the vial label. This article is the complete static reference: the formula, the lookup tables for every common compounded concentration of semaglutide and tirzepatide, and the worked math behind the most-searched dosing questions on Google. If you want an interactive version, the same math powers our GLP-1 unit converter.
The formula (the only one you need)
Every standard insulin syringe sold in the US is labeled U-100, which means 100 units = 1 mL. One unit is therefore exactly 0.01 mL of liquid — FDA's own dosing-error alert describes a U-100 syringe as 1 mL and a 5-unit dose as 0.05 mL[5]. This holds for every brand of U-100 syringe.
A compounded GLP-1 vial is a known concentration of active drug dissolved in sterile water — for example, 5 mg/mL tirzepatide or 10 mg/mL semaglutide. The concentration is printed on the vial label by the compounding pharmacy. To translate between "mg of drug" and "units on the syringe," use:
units = (mg × 100) ÷ concentration (mg/mL)
mg = (units × concentration (mg/mL)) ÷ 100
That is the entire math. Everything else in this article is the result of applying those two equations to every common dose at every common concentration.
Common compounded concentrations (2026)
Compounding pharmacies do not all use the same concentration. The most common ones we have observed across the GLP-1 injection providers we review as of 2026 are:
- Semaglutide: 2 mg/mL, 5 mg/mL, 10 mg/mL, and 25 mg/mL. The 2 mg/mL and 5 mg/mL strengths are by far the most common; the 10 mg/mL and 25 mg/mL strengths show up in higher-titration kits and stack vials.
- Tirzepatide: 5 mg/mL, 10 mg/mL, 20 mg/mL, 30 mg/mL, and 40 mg/mL. The 5 mg/mL and 10 mg/mL strengths are the most common starting kits; 20-40 mg/mL appear in maintenance and high-dose vials so the patient can draw fewer units per injection.
These are the columns in the reference tables below. If your vial is a concentration that is not listed, plug the number into the formula above (or use the interactive calculator) to get an exact answer.
Semaglutide: complete units-by-dose reference table
The rows below are the branded semaglutide dose steps (0.25, 0.5, 1, 1.7 and 2.4 mg for Wegovy[1]; 0.25, 0.5, 1 and 2 mg for Ozempic[2]) plus 1.5 mg, a common compounded intermediate step that is not on either label. Wegovy's label now also allows adults on 2.4 mg for at least 4 weeks to step up to a maximum of 7.2 mg weekly for weight reduction, delivered as a single 0.75 mL Wegovy HD pen[1]; we leave it off the table because at common compounded strengths it would be 144 units at 5 mg/mL or 360 units at 2 mg/mL, more than one 1 mL syringe holds. Here are the unit measurements at every common compounded concentration. Read across the row for your dose, find your vial concentration column, and that is the unit mark to draw to on the U-100 insulin syringe.
| Dose (mg) | 2 mg/mL | 5 mg/mL | 10 mg/mL | 25 mg/mL |
|---|---|---|---|---|
| 0.25 mg | 12.5 units | 5 units | 2.5 units | 1 units |
| 0.5 mg | 25 units | 10 units | 5 units | 2 units |
| 1 mg | 50 units | 20 units | 10 units | 4 units |
| 1.5 mg | 75 units | 30 units | 15 units | 6 units |
| 1.7 mg | 85 units | 34 units | 17 units | 6.8 units |
| 2 mg | 100 units | 40 units | 20 units | 8 units |
| 2.4 mg | 120 units | 48 units | 24 units | 9.6 units |
A few of these values do not land on a clean syringe gradation — for example, 1.7 mg at 25 mg/mL works out to 6.8 units, which a U-100 syringe with 1-unit gradations cannot draw precisely. In practice, your pharmacy should ship you a concentration that produces clean unit values for your prescribed dose. If your math gives you a fractional unit smaller than your syringe gradation, call the pharmacy before injecting. Any value above 100 units (for example, 2.4 mg at 2 mg/mL = 120 units) is more than a full 1 mL syringe, and any value above 50 units will not fit in a 0.5 mL syringe; if your dose lands there, the concentration or syringe is wrong for that dose and you should ask the pharmacy rather than splitting the draw on your own.
Magnitude comparison
Wegovy semaglutide standard titration ladder — milligram per weekly dose at each step. The 2.4 mg recommended maintenance dose is roughly 10x the 0.25 mg starter dose (the label also allows an optional step to a 7.2 mg maximum for adult weight reduction). Unit-on-syringe equivalents at a 5 mg/mL compounded concentration shown in notes. Source: Wegovy Prescribing Information (DailyMed).[1]
- Week 1-4 starter (0.25 mg)0.25 mg= 5 units on a 5 mg/mL vial
- Week 5-8 titration (0.5 mg)0.50 mg= 10 units on a 5 mg/mL vial
- Week 9-12 titration (1.0 mg)1.00 mg= 20 units on a 5 mg/mL vial
- Week 13-16 titration (1.7 mg)1.70 mg= 34 units on a 5 mg/mL vial
- Week 17+ recommended maintenance (2.4 mg)2.40 mg= 48 units on a 5 mg/mL vial
Tirzepatide: complete units-by-dose reference table
Same format for tirzepatide, covering the labeled dose steps: a 2.5 mg starter for 4 weeks, then 2.5 mg increases at least 4 weeks apart up to the 15 mg maximum for both Zepbound and Mounjaro in adults[3][4].
| Dose (mg) | 5 mg/mL | 10 mg/mL | 20 mg/mL | 30 mg/mL | 40 mg/mL |
|---|---|---|---|---|---|
| 2.5 mg | 50 units | 25 units | 12.5 units | 8.33 units | 6.25 units |
| 5 mg | 100 units | 50 units | 25 units | 16.67 units | 12.5 units |
| 7.5 mg | 150 units | 75 units | 37.5 units | 25 units | 18.75 units |
| 10 mg | 200 units | 100 units | 50 units | 33.33 units | 25 units |
| 12.5 mg | 250 units | 125 units | 62.5 units | 41.67 units | 31.25 units |
| 15 mg | 300 units | 150 units | 75 units | 50 units | 37.5 units |
Notice how dramatically the unit value drops as concentration rises. A 5 mg dose draws 100 units on a 5 mg/mL vial but only 12.5 units on a 40 mg/mL vial. Same drug, same milligrams, eight-fold difference in syringe volume. This is exactly why you cannot share unit instructions between patients on different concentrations. Note too that every entry above 100 units (7.5 mg and up at 5 mg/mL, 12.5 mg and up at 10 mg/mL) exceeds a full 1 mL syringe.
Worked example: How many units is 2.5 mg of tirzepatide?
This is the most-searched compounded GLP-1 dosing question on Google. The answer depends entirely on your vial concentration. Plugging 2.5 mg into the formula units = (mg × 100) / concentration:
- 5 mg/mL tirzepatide: (2.5 × 100) / 5 = 50 units
- 10 mg/mL tirzepatide: (2.5 × 100) / 10 = 25 units
- 20 mg/mL tirzepatide: (2.5 × 100) / 20 = 12.5 units
- 30 mg/mL tirzepatide: (2.5 × 100) / 30 ≈ 8.33 units (falls between marks; not precisely drawable on a standard syringe)
- 40 mg/mL tirzepatide: (2.5 × 100) / 40 = 6.25 units (also between marks)
The 5 mg/mL and 10 mg/mL answers (50 and 25 units) are the ones most patients land on, because those are the two most common starter-kit concentrations. At 30 and 40 mg/mL the 2.5 mg starter dose does not land on a syringe mark at all, which is one reason high-strength vials are a poor fit for the lowest doses.
Worked example: How many mg is 40 units of semaglutide?
Inverse formula: mg = (units × concentration) / 100. Plugging in 40 units of semaglutide:
- 2 mg/mL semaglutide: (40 × 2) / 100 = 0.8 mg
- 5 mg/mL semaglutide: (40 × 5) / 100 = 2.0 mg
- 10 mg/mL semaglutide: (40 × 10) / 100 = 4.0 mg
- 25 mg/mL semaglutide: (40 × 25) / 100 = 10.0 mg
This is the safety lesson in one example: 40 units delivers 0.8 mg on the lowest common concentration but 12.5x more drug on the highest. The recommended Wegovy maintenance dose is 2.4 mg and the label maximum is 7.2 mg[1], so a patient who accidentally drew 40 units from a 25 mg/mL vial would receive 10 mg — about four times the usual maintenance dose and more than any labeled Wegovy dose. This is why concentration is the load-bearing field on a compounded vial label.
Worked example: How many mg is 50 units of semaglutide?
- 2 mg/mL semaglutide: (50 × 2) / 100 = 1.0 mg
- 5 mg/mL semaglutide: (50 × 5) / 100 = 2.5 mg
- 10 mg/mL semaglutide: (50 × 10) / 100 = 5.0 mg
- 25 mg/mL semaglutide: (50 × 25) / 100 = 12.5 mg
Note that 5.0 mg and 12.5 mg of semaglutide both exceed the 2.4 mg recommended Wegovy maintenance dose[1] and the 2 mg Ozempic maximum dose[2], and 12.5 mg is also well above the 7.2 mg Wegovy maximum[1]. If you are drawing 50 units and your vial is 10 mg/mL or 25 mg/mL, stop and verify with your prescriber before injecting.
Worked example: How many mg is 20 units of tirzepatide?
- 5 mg/mL tirzepatide: (20 × 5) / 100 = 1.0 mg
- 10 mg/mL tirzepatide: (20 × 10) / 100 = 2.0 mg
- 20 mg/mL tirzepatide: (20 × 20) / 100 = 4.0 mg
- 30 mg/mL tirzepatide: (20 × 30) / 100 = 6.0 mg
- 40 mg/mL tirzepatide: (20 × 40) / 100 = 8.0 mg
20 units is a common "round number" instruction from telehealth clinicians, and the resulting milligram dose spans 1.0 mg (a sub-starter dose) to 8.0 mg (between the 7.5 mg and 10 mg titration steps of Zepbound[3]). Same syringe mark, five different milligram outcomes across the five concentrations.
Why concentration matters (the only safety point)
The single most important takeaway from this entire reference page is: the same number of units delivers a different milligram dose at every concentration. A unit is a volume measurement on the syringe, not a dose of drug. The drug content of that volume is set by the vial concentration, which is set by the compounding pharmacy.
Telehealth platforms often instruct patients in units rather than milligrams ("draw to the 25 mark") because units are what the patient actually has to do. That works only as long as the concentration in the vial does not change. The most common dosing-error scenarios we see are:
- The pharmacy switched concentrations between refills and the patient kept drawing the old unit count.
- A patient on tirzepatide assumed semaglutide unit instructions translate (they do not — the concentrations are different).
- A patient stacked vials from two pharmacies with different concentrations and used the unit count from the wrong vial.
- A friend or partner started on the same drug at a different concentration and the patient used their unit count.
Every one of those errors is preventable by re-reading the vial label and re-running the unit conversion every time you open a new vial.
What FDA has documented about unit-conversion errors
This is not a hypothetical risk. In a July 2024 alert, FDA reported adverse events, some requiring hospitalization, linked to dosing errors with compounded semaglutide in multiple-dose vials[5]. Most reports involved patients drawing more than the prescribed dose, receiving five to 20 times the intended amount; in several, patients told to draw 5 units (0.05 mL) with a U-100 syringe drew 50 units instead. FDA also described clinicians miscalculating the mg-to-units conversion, causing 5- to 10-fold overdoses — in one case a prescriber intended 0.25 mg (5 units) but wrote 25 units[5]. That example matches the 5 mg/mL column of the table above, and it is exactly the arithmetic this page exists to check. FDA's current guidance on unapproved GLP-1s extends the dosing concern to compounded tirzepatide as well, including adverse events tied to doses or titration faster than the approved labels allow, and asks patients to talk with their prescriber or compounder about how to measure the intended dose[6].
Compounded semaglutide and tirzepatide are not FDA-approved, and their legal footing changed after the shortages ended. FDA declared the tirzepatide injection shortage resolved on December 19, 2024, and the semaglutide injection shortage resolved on February 21, 2025; the transition periods for pharmacies and outsourcing facilities to stop making essentially-copy versions have since ended, and FDA states that neither drug is on its shortage list or the 503B bulks list[7]. State-licensed pharmacies can still compound in limited circumstances, so compounded vials remain in circulation — which is why the conversion math on this page still matters, and why the concentration printed on your own vial label always governs.
How to find your concentration
The concentration should be printed on the vial label by the compounding pharmacy. Look for a value formatted like 5 mg/mL, 10 mg/mL, or 2.5 mg/mL. It is usually printed near the drug name and the lot number. If the label only lists the total mg in the vial and the total mL, divide the two:
concentration (mg/mL) = total mg in vial ÷ total mL in vial
For example, a vial labeled "25 mg total / 5 mL" is a 5 mg/mL vial. A vial labeled "10 mg total / 2 mL" is a 5 mg/mL vial. A vial labeled "20 mg total / 2 mL" is a 10 mg/mL vial.
If the concentration is not on the label and you cannot derive it from total mg and total mL, call the pharmacy before injecting. Do not guess. Do not assume it is the same as your last vial. Do not assume it is the same as a friend's vial. The compounding pharmacy keeps the concentration on file for every batch they ship.
Use the interactive calculator instead
Static tables answer the most common cases, but if your dose or concentration is off the chart, our interactive tool runs the same formula in real time and shows you the exact unit mark to draw to (rounded to the nearest 0.5 unit, since that is what an insulin syringe can actually deliver):
- GLP-1 Unit Converter — interactive mg ↔ units calculator with rounding to the nearest syringe gradation. Same engine as the tables on this page; built for the cases the tables do not cover.
Frequently Asked Questions
Related research and tools
- GLP-1 Unit Converter (interactive) — the live calculator that runs the same formula as this page, with rounding to the nearest syringe gradation
- Compounded tirzepatide dosage in units — why the same number of units is a different dose from every vial, worked through at each common concentration
- Compounded semaglutide dosage in units — the same conversion for semaglutide, and the errors documented when the two scales are confused
- Syringe dead space and GLP-1 dosing — the fixed volume left in the needle and hub, and why it costs a small draw proportionally far more than a large one
- Compounded GLP-1 reconstitution and mixing guide — how concentration is set in the first place when you reconstitute a freeze-dried vial with bacteriostatic water
- How to inject a GLP-1: step-by-step technique — once you have the unit count, this is the injection procedure
- Wegovy pen vs compounded vial: practical differences — why brand-name pens dose in mg automatically and compounded vials force you to do this math
Further reading
- Wegovy dose-ladder cheat sheet
- Zepbound titration schedule cheat sheet
- Mounjaro dose-increase timing cheat sheet
References
- 1.Novo Nordisk; U.S. National Library of Medicine. WEGOVY (semaglutide) injection; WEGOVY (semaglutide) tablets — US Prescribing Information (DailyMed SetID ee06186f-2aa3-4990-a760-757579d8f77b). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- 2.Novo Nordisk; U.S. National Library of Medicine. OZEMPIC (semaglutide) injection — US Prescribing Information (DailyMed SetID adec4fd2-6858-4c99-91d4-531f5f2a2d79). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79
- 3.Eli Lilly and Company; U.S. National Library of Medicine. ZEPBOUND (tirzepatide) injection — US Prescribing Information (DailyMed SetID 487cd7e7-434c-4925-99fa-aa80b1cc776b). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- 4.Eli Lilly and Company; U.S. National Library of Medicine. MOUNJARO (tirzepatide) injection — US Prescribing Information (DailyMed SetID d2d7da5d-ad07-4228-955f-cf7e355c8cc0). DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- 5.U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
- 6.U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. FDA Drug Alerts and Statements. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- 7.U.S. Food and Drug Administration. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA Drug Alerts and Statements. 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Wegovy · Drugs and brands
- Ozempic · Drugs and brands
- Zepbound · Drugs and brands
- Mounjaro · Drugs and brands
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Titration · Dosing
Where to get tirzepatide (Mounjaro / Zepbound) safely: vetted online providers
Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Oak
Compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Read full review →From $250/mo (starting dose)
Get started →From $149/mo
Get started →From $209/mo (2-month plan rate)
Get started →